MCI
54
15
19
19
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 54 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
11%
2 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 19 completed trials
Clinical Trials (54)
Prevalence of Mild Cognitive Impairment and Dementia in Patients Admitted to Non-neurological Rehabilitation Wards
The Effects of Some Antihyperglycemic Drugs on Cognitive Function and Risk of Depression of Diabetic Patients
The Effect of Lavender Aromatherapy on Cognitive Function in Older Adults With Mild Cognitive Impairment
Validation and Reliability of the Turkish Version of the Montreal Cognitive Assessment-Basic (MoCA-B) in Individuals With Low Educational Level
Telehealth-Adapted Compensatory Training and Intervention for Cognition
Tailored Brain Health Insights Through Nurturing Knowledge-based Change - Stakeholder-driven, Human-centered, AI-powered Refinement for Prevention
Acute Oral Ketone Monoester Supplementation and Resting-state Brain Connectivity
A Phase I Study of [18F]Flortaucipir PET Imaging in Chinese Subjects: Safety, Pharmacokinetics, Biodistribution, Radiation Dosimetry, and Preliminary Diagnostic Efficacy
Personalized Closed-Loop Brain Stimulation for Patients With Mild Cognitive Impairment
Accexible Speech Analysis for MCI Detection and Monitoring in Colombia
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)
Ketogenic Diet to Reduce Osteoarthritis Pain in MCI
FACE Phase II (a Stage II Trial)
Impact of Nutrition, Sleep, and Physical Activity on Intellectual Function and Muscle Mass in Older Adults
Cognitive-Motor Training for AD/ADRD Prevention
Studying the Effects of Digital Interventions on Cognition, Wellbeing, Stress, and Sleep in Older Adults
Enhancing Attention and Wellbeing Using Digital Therapeutics
Accelerating Cognitive Gains From Digital Inverventions With Noninvasive Brain Stimulation
Neurocognitive Assessment Platform 4 Alzheimer
Validation of the Montreal Cognitive Assessment (MoCA) Version 8.x and MoCA-MIS in Greece.